Coronavirus Update: Sinovac Gets $15m Towards CoronaVac Phase II, Remdesivir Early Access In UK
Progress For China's Vaccines
Executive Summary
Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.